Busulfan inhibits Pseudomonas aeruginosa growth and reduces biofilm biomass and pyocyanin production

BackgroundPseudomonas aeruginosa remains a serious threat in clinical settings, especially among patients who are immunocompromised, receiving chemotherapy, or in intensive care units. With the rise of antibiotic resistance, drug repurposing offers a promising alternative strategy. Busulfan, an anti...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Needa A. Bahkali, Rhodanne Nicole A. Lambarte, Terrence S. Sumague, Turki M. Dawoud, Khalid S. Almaary, Abdurahman A. Niazy
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-01-01
Edice:	Frontiers in Cellular and Infection Microbiology
Témata:	busulfan anticancer drug repurposing Pseudomonas aeruginosa virulence factors antibacterial
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1721773/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!